Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cholera Vaccines Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Dukoral
1.2.3 Shanchol
1.2.4 Vaxchora
1.2.5 Others
1.3 Market by Application
1.3.1 Global Cholera Vaccines Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Oral
1.3.3 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cholera Vaccines Market Perspective (2018-2033)
2.2 Cholera Vaccines Growth Trends by Region
2.2.1 Global Cholera Vaccines Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Cholera Vaccines Historic Market Size by Region (2018-2023)
2.2.3 Cholera Vaccines Forecasted Market Size by Region (2024-2033)
2.3 Cholera Vaccines Market Dynamics
2.3.1 Cholera Vaccines Industry Trends
2.3.2 Cholera Vaccines Market Drivers
2.3.3 Cholera Vaccines Market Challenges
2.3.4 Cholera Vaccines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cholera Vaccines Players by Revenue
3.1.1 Global Top Cholera Vaccines Players by Revenue (2018-2023)
3.1.2 Global Cholera Vaccines Revenue Market Share by Players (2018-2023)
3.2 Global Cholera Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cholera Vaccines Revenue
3.4 Global Cholera Vaccines Market Concentration Ratio
3.4.1 Global Cholera Vaccines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cholera Vaccines Revenue in 2022
3.5 Cholera Vaccines Key Players Head office and Area Served
3.6 Key Players Cholera Vaccines Product Solution and Service
3.7 Date of Enter into Cholera Vaccines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cholera Vaccines Breakdown Data by Type
4.1 Global Cholera Vaccines Historic Market Size by Type (2018-2023)
4.2 Global Cholera Vaccines Forecasted Market Size by Type (2024-2033)
5 Cholera Vaccines Breakdown Data by Application
5.1 Global Cholera Vaccines Historic Market Size by Application (2018-2023)
5.2 Global Cholera Vaccines Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Cholera Vaccines Market Size (2018-2033)
6.2 North America Cholera Vaccines Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Cholera Vaccines Market Size by Country (2018-2023)
6.4 North America Cholera Vaccines Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cholera Vaccines Market Size (2018-2033)
7.2 Europe Cholera Vaccines Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Cholera Vaccines Market Size by Country (2018-2023)
7.4 Europe Cholera Vaccines Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cholera Vaccines Market Size (2018-2033)
8.2 Asia-Pacific Cholera Vaccines Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Cholera Vaccines Market Size by Region (2018-2023)
8.4 Asia-Pacific Cholera Vaccines Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cholera Vaccines Market Size (2018-2033)
9.2 Latin America Cholera Vaccines Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Cholera Vaccines Market Size by Country (2018-2023)
9.4 Latin America Cholera Vaccines Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cholera Vaccines Market Size (2018-2033)
10.2 Middle East & Africa Cholera Vaccines Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Cholera Vaccines Market Size by Country (2018-2023)
10.4 Middle East & Africa Cholera Vaccines Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Shantha Biotechnics Private Limited
11.1.1 Shantha Biotechnics Private Limited Company Detail
11.1.2 Shantha Biotechnics Private Limited Business Overview
11.1.3 Shantha Biotechnics Private Limited Cholera Vaccines Introduction
11.1.4 Shantha Biotechnics Private Limited Revenue in Cholera Vaccines Business (2018-2023)
11.1.5 Shantha Biotechnics Private Limited Recent Development
11.2 PaxVax, Inc.
11.2.1 PaxVax, Inc. Company Detail
11.2.2 PaxVax, Inc. Business Overview
11.2.3 PaxVax, Inc. Cholera Vaccines Introduction
11.2.4 PaxVax, Inc. Revenue in Cholera Vaccines Business (2018-2023)
11.2.5 PaxVax, Inc. Recent Development
11.3 Valneva SE
11.3.1 Valneva SE Company Detail
11.3.2 Valneva SE Business Overview
11.3.3 Valneva SE Cholera Vaccines Introduction
11.3.4 Valneva SE Revenue in Cholera Vaccines Business (2018-2023)
11.3.5 Valneva SE Recent Development
11.4 Merck and Co., Inc.
11.4.1 Merck and Co., Inc. Company Detail
11.4.2 Merck and Co., Inc. Business Overview
11.4.3 Merck and Co., Inc. Cholera Vaccines Introduction
11.4.4 Merck and Co., Inc. Revenue in Cholera Vaccines Business (2018-2023)
11.4.5 Merck and Co., Inc. Recent Development
11.5 GlaxoSmithKline plc (GSK)
11.5.1 GlaxoSmithKline plc (GSK) Company Detail
11.5.2 GlaxoSmithKline plc (GSK) Business Overview
11.5.3 GlaxoSmithKline plc (GSK) Cholera Vaccines Introduction
11.5.4 GlaxoSmithKline plc (GSK) Revenue in Cholera Vaccines Business (2018-2023)
11.5.5 GlaxoSmithKline plc (GSK) Recent Development
11.6 Astellas Pharma, Inc.
11.6.1 Astellas Pharma, Inc. Company Detail
11.6.2 Astellas Pharma, Inc. Business Overview
11.6.3 Astellas Pharma, Inc. Cholera Vaccines Introduction
11.6.4 Astellas Pharma, Inc. Revenue in Cholera Vaccines Business (2018-2023)
11.6.5 Astellas Pharma, Inc. Recent Development
11.7 Pfizer, Inc.
11.7.1 Pfizer, Inc. Company Detail
11.7.2 Pfizer, Inc. Business Overview
11.7.3 Pfizer, Inc. Cholera Vaccines Introduction
11.7.4 Pfizer, Inc. Revenue in Cholera Vaccines Business (2018-2023)
11.7.5 Pfizer, Inc. Recent Development
11.8 Emergent BioSolutions, Inc.
11.8.1 Emergent BioSolutions, Inc. Company Detail
11.8.2 Emergent BioSolutions, Inc. Business Overview
11.8.3 Emergent BioSolutions, Inc. Cholera Vaccines Introduction
11.8.4 Emergent BioSolutions, Inc. Revenue in Cholera Vaccines Business (2018-2023)
11.8.5 Emergent BioSolutions, Inc. Recent Development
11.9 Mitsubishi Tanabe Pharma Corporation
11.9.1 Mitsubishi Tanabe Pharma Corporation Company Detail
11.9.2 Mitsubishi Tanabe Pharma Corporation Business Overview
11.9.3 Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Introduction
11.9.4 Mitsubishi Tanabe Pharma Corporation Revenue in Cholera Vaccines Business (2018-2023)
11.9.5 Mitsubishi Tanabe Pharma Corporation Recent Development
11.10 Takeda Pharmaceutical Co., Ltd.
11.10.1 Takeda Pharmaceutical Co., Ltd. Company Detail
11.10.2 Takeda Pharmaceutical Co., Ltd. Business Overview
11.10.3 Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Introduction
11.10.4 Takeda Pharmaceutical Co., Ltd. Revenue in Cholera Vaccines Business (2018-2023)
11.10.5 Takeda Pharmaceutical Co., Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Cholera Vaccines Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Dukoral
Table 3. Key Players of Shanchol
Table 4. Key Players of Vaxchora
Table 5. Key Players of Others
Table 6. Global Cholera Vaccines Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Cholera Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Cholera Vaccines Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Cholera Vaccines Market Share by Region (2018-2023)
Table 10. Global Cholera Vaccines Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Cholera Vaccines Market Share by Region (2024-2033)
Table 12. Cholera Vaccines Market Trends
Table 13. Cholera Vaccines Market Drivers
Table 14. Cholera Vaccines Market Challenges
Table 15. Cholera Vaccines Market Restraints
Table 16. Global Cholera Vaccines Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Cholera Vaccines Market Share by Players (2018-2023)
Table 18. Global Top Cholera Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cholera Vaccines as of 2022)
Table 19. Ranking of Global Top Cholera Vaccines Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Cholera Vaccines Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Cholera Vaccines Product Solution and Service
Table 23. Date of Enter into Cholera Vaccines Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Cholera Vaccines Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Cholera Vaccines Revenue Market Share by Type (2018-2023)
Table 27. Global Cholera Vaccines Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Cholera Vaccines Revenue Market Share by Type (2024-2033)
Table 29. Global Cholera Vaccines Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Cholera Vaccines Revenue Market Share by Application (2018-2023)
Table 31. Global Cholera Vaccines Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Cholera Vaccines Revenue Market Share by Application (2024-2033)
Table 33. North America Cholera Vaccines Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Cholera Vaccines Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Cholera Vaccines Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Cholera Vaccines Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Cholera Vaccines Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Cholera Vaccines Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Cholera Vaccines Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Cholera Vaccines Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Cholera Vaccines Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Cholera Vaccines Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Cholera Vaccines Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Cholera Vaccines Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Cholera Vaccines Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Cholera Vaccines Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Cholera Vaccines Market Size by Country (2024-2033) & (US$ Million)
Table 48. Shantha Biotechnics Private Limited Company Detail
Table 49. Shantha Biotechnics Private Limited Business Overview
Table 50. Shantha Biotechnics Private Limited Cholera Vaccines Product
Table 51. Shantha Biotechnics Private Limited Revenue in Cholera Vaccines Business (2018-2023) & (US$ Million)
Table 52. Shantha Biotechnics Private Limited Recent Development
Table 53. PaxVax, Inc. Company Detail
Table 54. PaxVax, Inc. Business Overview
Table 55. PaxVax, Inc. Cholera Vaccines Product
Table 56. PaxVax, Inc. Revenue in Cholera Vaccines Business (2018-2023) & (US$ Million)
Table 57. PaxVax, Inc. Recent Development
Table 58. Valneva SE Company Detail
Table 59. Valneva SE Business Overview
Table 60. Valneva SE Cholera Vaccines Product
Table 61. Valneva SE Revenue in Cholera Vaccines Business (2018-2023) & (US$ Million)
Table 62. Valneva SE Recent Development
Table 63. Merck and Co., Inc. Company Detail
Table 64. Merck and Co., Inc. Business Overview
Table 65. Merck and Co., Inc. Cholera Vaccines Product
Table 66. Merck and Co., Inc. Revenue in Cholera Vaccines Business (2018-2023) & (US$ Million)
Table 67. Merck and Co., Inc. Recent Development
Table 68. GlaxoSmithKline plc (GSK) Company Detail
Table 69. GlaxoSmithKline plc (GSK) Business Overview
Table 70. GlaxoSmithKline plc (GSK) Cholera Vaccines Product
Table 71. GlaxoSmithKline plc (GSK) Revenue in Cholera Vaccines Business (2018-2023) & (US$ Million)
Table 72. GlaxoSmithKline plc (GSK) Recent Development
Table 73. Astellas Pharma, Inc. Company Detail
Table 74. Astellas Pharma, Inc. Business Overview
Table 75. Astellas Pharma, Inc. Cholera Vaccines Product
Table 76. Astellas Pharma, Inc. Revenue in Cholera Vaccines Business (2018-2023) & (US$ Million)
Table 77. Astellas Pharma, Inc. Recent Development
Table 78. Pfizer, Inc. Company Detail
Table 79. Pfizer, Inc. Business Overview
Table 80. Pfizer, Inc. Cholera Vaccines Product
Table 81. Pfizer, Inc. Revenue in Cholera Vaccines Business (2018-2023) & (US$ Million)
Table 82. Pfizer, Inc. Recent Development
Table 83. Emergent BioSolutions, Inc. Company Detail
Table 84. Emergent BioSolutions, Inc. Business Overview
Table 85. Emergent BioSolutions, Inc. Cholera Vaccines Product
Table 86. Emergent BioSolutions, Inc. Revenue in Cholera Vaccines Business (2018-2023) & (US$ Million)
Table 87. Emergent BioSolutions, Inc. Recent Development
Table 88. Mitsubishi Tanabe Pharma Corporation Company Detail
Table 89. Mitsubishi Tanabe Pharma Corporation Business Overview
Table 90. Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Product
Table 91. Mitsubishi Tanabe Pharma Corporation Revenue in Cholera Vaccines Business (2018-2023) & (US$ Million)
Table 92. Mitsubishi Tanabe Pharma Corporation Recent Development
Table 93. Takeda Pharmaceutical Co., Ltd. Company Detail
Table 94. Takeda Pharmaceutical Co., Ltd. Business Overview
Table 95. Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Product
Table 96. Takeda Pharmaceutical Co., Ltd. Revenue in Cholera Vaccines Business (2018-2023) & (US$ Million)
Table 97. Takeda Pharmaceutical Co., Ltd. Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cholera Vaccines Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Cholera Vaccines Market Share by Type: 2022 VS 2033
Figure 3. Dukoral Features
Figure 4. Shanchol Features
Figure 5. Vaxchora Features
Figure 6. Others Features
Figure 7. Global Cholera Vaccines Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Cholera Vaccines Market Share by Application: 2022 VS 2033
Figure 9. Oral Case Studies
Figure 10. Others Case Studies
Figure 11. Cholera Vaccines Report Years Considered
Figure 12. Global Cholera Vaccines Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Cholera Vaccines Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Cholera Vaccines Market Share by Region: 2022 VS 2033
Figure 15. Global Cholera Vaccines Market Share by Players in 2022
Figure 16. Global Top Cholera Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cholera Vaccines as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Cholera Vaccines Revenue in 2022
Figure 18. North America Cholera Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Cholera Vaccines Market Share by Country (2018-2033)
Figure 20. United States Cholera Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Cholera Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Cholera Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Cholera Vaccines Market Share by Country (2018-2033)
Figure 24. Germany Cholera Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Cholera Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Cholera Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Cholera Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Cholera Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Cholera Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Cholera Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Cholera Vaccines Market Share by Region (2018-2033)
Figure 32. China Cholera Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Cholera Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Cholera Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Cholera Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Cholera Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Cholera Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Cholera Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Cholera Vaccines Market Share by Country (2018-2033)
Figure 40. Mexico Cholera Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Cholera Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Cholera Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Cholera Vaccines Market Share by Country (2018-2033)
Figure 44. Turkey Cholera Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Cholera Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Shantha Biotechnics Private Limited Revenue Growth Rate in Cholera Vaccines Business (2018-2023)
Figure 47. PaxVax, Inc. Revenue Growth Rate in Cholera Vaccines Business (2018-2023)
Figure 48. Valneva SE Revenue Growth Rate in Cholera Vaccines Business (2018-2023)
Figure 49. Merck and Co., Inc. Revenue Growth Rate in Cholera Vaccines Business (2018-2023)
Figure 50. GlaxoSmithKline plc (GSK) Revenue Growth Rate in Cholera Vaccines Business (2018-2023)
Figure 51. Astellas Pharma, Inc. Revenue Growth Rate in Cholera Vaccines Business (2018-2023)
Figure 52. Pfizer, Inc. Revenue Growth Rate in Cholera Vaccines Business (2018-2023)
Figure 53. Emergent BioSolutions, Inc. Revenue Growth Rate in Cholera Vaccines Business (2018-2023)
Figure 54. Mitsubishi Tanabe Pharma Corporation Revenue Growth Rate in Cholera Vaccines Business (2018-2023)
Figure 55. Takeda Pharmaceutical Co., Ltd. Revenue Growth Rate in Cholera Vaccines Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed